Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Taxes: 2015-2025

Historic Change in Taxes for Enanta Pharmaceuticals (ENTA) over the last 11 years, with Sep 2025 value amounting to $33.8 million.

  • Enanta Pharmaceuticals' Change in Taxes rose 7434.91% to $31.9 million in Q2 2025 from the same period last year, while for Jun 2025 it was $33.3 million, marking a year-over-year increase of 409.77%. This contributed to the annual value of $33.8 million for FY2025, which is 3295.48% up from last year.
  • Latest data reveals that Enanta Pharmaceuticals reported Change in Taxes of $33.8 million as of FY2025, which was up 3,295.48% from $995,000 recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Change in Taxes registered a high of $33.8 million during FY2025, and its lowest value of -$8.5 million during FY2022.
  • For the 3-year period, Enanta Pharmaceuticals' Change in Taxes averaged around $12.4 million, with its median value being $2.3 million (2023).
  • As far as peak fluctuations go, Enanta Pharmaceuticals' Change in Taxes tumbled by 135.26% in 2022, and later soared by 3,295.48% in 2025.
  • Yearly analysis of 5 years shows Enanta Pharmaceuticals' Change in Taxes stood at $24.2 million in 2021, then crashed by 135.26% to -$8.5 million in 2022, then skyrocketed by 126.78% to $2.3 million in 2023, then tumbled by 56.47% to $995,000 in 2024, then surged by 3,295.48% to $33.8 million in 2025.